Impaired insulin signaling, a well-known abnormality in the metabolic syndrome, leads to lower uptake of glucose in skeletal muscles, and an upregulation of hepatic gluconeogenesis resulting in hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.